|
|
|
|||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
First published online December 12, 2006
doi: 10.1242/10.1242/dev.02701

1 Department of Human Genetics, University of Utah, 15 N 2030 E RM 2100, Salt
Lake City, UT 84112-5330, USA.
2 Division of Radiobiology, University of Utah, 729 Arapeen Drive #2334, Salt
Lake City, UT 84108-1218, USA.
Author for correspondence (e-mail:
suzi.mansour{at}genetics.utah.edu)
Accepted 17 October 2006
Mitogen-activated protein kinase (MAPK) pathways are major mediators of extracellular signals that are transduced to the nucleus. MAPK signaling is attenuated at several levels, and one class of dual-specificity phosphatases, the MAPK phosphatases (MKPs), inhibit MAPK signaling by dephosphorylating activated MAPKs. Several of the MKPs are themselves induced by the signaling pathways they regulate, forming negative feedback loops that attenuate the signals. We show here that in mouse embryos, Fibroblast growth factor receptors (FGFRs) are required for transcription of Dusp6, which encodes MKP3, an extracellular signal-regulated kinase (ERK)-specific MKP. Targeted inactivation of Dusp6 increases levels of phosphorylated ERK, as well as the pERK target, Erm, and transcripts initiated from the Dusp6 promoter itself. Finally, the Dusp6 mutant allele causes variably penetrant, dominant postnatal lethality, skeletal dwarfism, coronal craniosynostosis and hearing loss; phenotypes that are also characteristic of mutations that activate FGFRs inappropriately. Taken together, these results show that DUSP6 serves in vivo as a negative feedback regulator of FGFR signaling and suggest that mutations in DUSP6 or related genes are candidates for causing or modifying unexplained cases of FGFR-like syndromes.
Key words: Mkp3, Pyst1, Dual specificity phosphatase, Craniosynostosis, Middle ear, Otic capsule, Mouse
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
![]() |
S. L. Mansour, S. R.F. Twigg, R. M. Freeland, S. A. Wall, C. Li, and A. O.M. Wilkie Hearing loss in a mouse model of Muenke syndrome Hum. Mol. Genet., January 1, 2009; 18(1): 43 - 50. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Maillet, N. H. Purcell, M. A. Sargent, A. J. York, O. F. Bueno, and J. D. Molkentin DUSP6 (MKP3) Null Mice Show Enhanced ERK1/2 Phosphorylation at Baseline and Increased Myocyte Proliferation in the Heart Affecting Disease Susceptibility J. Biol. Chem., November 7, 2008; 283(45): 31246 - 31255. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Boutros, E. Chevet, and P. Metrakos Mitogen-Activated Protein (MAP) Kinase/MAP Kinase Phosphatase Regulation: Roles in Cell Growth, Death, and Cancer Pharmacol. Rev., September 1, 2008; 60(3): 261 - 310. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. V. Mortensen, M. B. Larsen, B. M. Prasad, and S. G. Amara Genetic Complementation Screen Identifies a Mitogen-activated Protein Kinase Phosphatase, MKP3, as a Regulator of Dopamine Transporter Trafficking Mol. Biol. Cell, July 1, 2008; 19(7): 2818 - 2829. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-Y. Fan, M. Shimada, Z. Liu, N. Cahill, N. Noma, Y. Wu, J. Gossen, and J. S. Richards Selective expression of KrasG12D in granulosa cells of the mouse ovary causes defects in follicle development and ovulation Development, June 15, 2008; 135(12): 2127 - 2137. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Cotton, M. K. O'Bryan, and B. T. Hinton Cellular Signaling by Fibroblast Growth Factors (FGFs) and Their Receptors (FGFRs) in Male Reproduction Endocr. Rev., April 1, 2008; 29(2): 193 - 216. [Abstract] [Full Text] [PDF] |
||||